Pfizer, Inc. v. Biogen, Inc. > Summary
Court Case Number IPR2017-01168
Filing Date Apr 28, 2017
Institution Decision Date Nov 6, 2017
Decision Date Oct 31, 2018
Court Patent Trial and Appeal Board
Status Final Written Decision
Appeal2019-1364
Administrative JudgesErica A. Franklin, Sheridan K. Snedden, Jacqueline T. Harlow
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 2, 3, 4, 5
Claims Instituted: 1, 2, 3, 4, 5
Claims Invalidated: 1, 2, 3, 4, 5
Petitioner
Patent Owner
Petitioner Attorneys
11Pfizer
Attorney Name: Jovial Wong
Winston & Strawn
Pfizer
Attorney Name: Charles B. Klein
Winston & Strawn
Pfizer
Attorney Name: Eimeric Reig-Plessis
Winston & Strawn
Pfizer
Attorney Name: Ilan Wurman
Winston & Strawn
Pfizer
Attorney Name: Matthew J. Mezger
Winston & Strawn
Pfizer
Attorney Name: John P. Scheibeler
White & Case
Pfizer
Attorney Name: Dimitrios T. Drivas
White & Case
Pfizer
Attorney Name: Ryan Johnson
White & Case
Pfizer Legal Division 2
Attorney Name: Howard Ozer
Winston & Strawn
Pfizer
Attorney Name: Robert J. Soiffer
Dana-Farber Cancer Institute
Pfizer
Attorney Name: Scott Michael Bennett
Yale University
Patent Owner Attorneys
8Biogen
Attorney Name: Gary N. Frischling
Irell & Manella LLP
Biogen
Attorney Name: Keith A. Orso
Irell & Manella LLP
Biogen
Attorney Name: Yite John Lu
Irell & Manella LLP
Biogen
Attorney Name: Michael R. Fleming
Irell & Manella LLP
Biogen
Attorney Name: David I. Gindler
Irell & Manella LLP
Irell & Manella LLP
Attorney Name: Susan M. Langworthy
Irell & Manella LLP
Irell & Manella LLP
Attorney Name: Pia S. Kamath
Irell & Manella LLP
Biogen
Attorney Name: Brad S. Kahl
Irell & Manella LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
08821873 | Treatment of diffuse large-cell lymphoma with anti-CD20 antibody | Sep 2, 2014 |